Jejunal inflammatory myofibroblastic tumor: a rare entity
DOI:
https://doi.org/10.18203/2349-2902.isj20172418Keywords:
Inflammatory fibrosarcoma, Inflammatory myofibroblastic tumor, JejunumAbstract
Inflammatory myofibroblastic tumor is one of the rare solid tumor occurring in children. Main stay of treatment is surgical resection and in some corticosteroids or NSAIDS may be useful. Here, a case of 3-year-old female with inflammatory myofibroblastic tumor of jejunum is presented, that was evaluated clinically, investigated radiologically and finally histopathology confirmed the diagnosis. No complications occurred at peri and postoperative period. The patient was on regular follow-up and no recurrence had been documented yet in 1 year of follow up. In this article, we reviewed the literature for inflammatory myofibroblastic tumor.
Metrics
References
Pettinato G, Manivel JC, Dehner LP. Inflammatory myofibroblastic tumor (plasma cell granuloma): clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol. 1990;94(5):538-46.
Palaskar S, Koshti S, Maralingannavar M, Bartake A. Inflammatory myofibroblastic tumor. Contemp Clin Dentistry. 2011;2(4):274.
Freud E, Bilik R, Yaniv I, Horev G, Cohen D, Mimouni M, et al. Inflammatory pseudotumor in childhood: a diagnostic and therapeutic dilemma. Arch Surg. 1991;126(5):653-5.
Bahadori M, Liebow AA. Plasma cell granulomas of the lung. Cancer. 1973;31(1):191-208.
Tang TT, Segura AD, Oechler HW, Harb JM, Adair SE, Gregg DC, et al. Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children. Cancer. 1990;65(7):1626-34.
Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor) a clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19(8):859-72.
Monzon CM, Gilchrist GS, Burgert EO, O'Connell EJ, Telander RL, Hoffman AD, et al. Plasma cell granuloma of the lung in children. Pediatrics. 1982;70(2):268-74.
Attili SV, Chandra CR, Hemant DK, Bapsy PP, RamaRao C, Anupama G. Retroperitoneal inflammatory myofibroblastic tumor. World J Surg Oncol. 2005;3(1):1.
Scully RE, Mark EJ, Mcneely WF, Ebeling SH. Weekly clinicopathological exercises. N Engl J Med. 1997;337(12):839-45.
Erkan N, Yildirim M, Yilmaz C, Yagci A. Inflammatory pseudo-tumour as an unusual cause of colonic obstruction: a case report. Acta chirurgica Belgica. 2004;1(4):462-4.
DiFiore JW, Goldblum JR. Inflammatory myofibroblastic tumor of the small intestine. J Am Coll Surg. 2002;194(4):502-6.
Levy S, Sauvanet A, Diebold MD, Marcus C, Da Costa N, Thiefin G. Spontaneous regression of an inflammatory pseudotumor of the liver presenting as an obstructing malignant biliary tumor. Gastrointest Endosc. 2001;53(3):371-4.
Slavotinek JP, Bourne AJ, Sage MR, Freeman JK. Inflammatory pseudotumour of the pancreas in a child. Pediatr Radiol. 2000;30(11):801-3.
Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509-20.
Fletcher CD, Unni KK, Mertens F, eds. Pathology and genetics of tumours of soft tissue and bone. Iarc; 2002.
Al‐Nafussi A, Wong NA. Intra‐abdominal spindle cell lesions: a review and practical aids to diagnosis. Histopathology. 2001;38(5):387-402.
Koyuncuer A. Inflammatory myofibroblastic tumor of the small-bowel mesentery: a case report of nonspecific clinical presentation and a review of the literature. Int J Surg Case Rep. 2014;5(12):1214-7.
Biselli R, Ferlini C, Fattorossi A, Boldrini R, Bosman C. Inflammatory myofibroblastic tumor (inflammatory pseudotumor): DNA flow cytometric analysis of nine pediatric cases. Cancer. 1996;77(4):778-84.
Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum: a tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol. 1991;15(12):1146-56.
Tothova Z, Wagner AJ. Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors. Curr Opin oncol. 2012;24(4):409-13.
Singer S, Nielsen T, Antonescu CR. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. 9th ed. International edition. Philadelphia, PA: Lippincott Williams and Wilkins; 2012:1540.
Murga-Zamalloa C, Lim MS. ALK-driven tumors and targeted therapy: focus on crizotinib. Pharmgenomics Pers Med. 2014;7:87-94.
Carswell C, Chataway J. The successful long-term management of an intracranial inflammatory myofibroblastic tumor with corticosteroids. Clin Neurol Neurosurg. 2012;114(1):77-9.